IFNG and breast carcinoma: On the other hand, oral administration of MH to breast cancer-bearing Sprague Dawley rats resulted in a significant reduction in tumor growth, which was accompanied by an increase in the serum level of the pro-inflammatory cytokine interferon-gamma (IFN-γ), indicating an immunomodulatory anti-tumor effect of MH (17).